According to a recent MDDI article, people suffering from meniscus surgery will likely have a new treatment option. The FDA has declared Active Implants’ NUsurface meniscus implant a breakthrough device. The artificial meniscus is currently available in Europe, but still needs clearance by the FDA to hit the market in the United States. The FDA’s breakthrough devices program was established to speed up the development and review process for medical devices that are novel or offer new technology for patients with “life-threatening or irreversibly debilitating conditions.”
First Artificial Meniscus is an FDA Breakthrough Device
The FDA has designated the first artificial meniscus implant a breakthrough device, expediting its review process.
Sep 26, 2019
Discover the right packaging solutions for life sciences in Philadelphia
Explore innovative packaging and supply chain solutions for the life sciences at the largest PACK EXPO East in history, March 18–20. Get ideas from 400+ top exhibitors and connect with colleagues and industry experts—all in one convenient location!
Read More